When we drink little, we produce less urine. But how is this process regulated? An international team of scientists led by Professor Kai Schmidt-Ott of the Max Delbrück Center for Molecular Medicine (MDC) has now shed light on how the kidneys concentrate urine.
A new study from Keck Medicine of USC finds that data from a novel recorder can be used to objectively measure surgeons' proficiency in robotic-assisted prostate cancer surgery.
A University of Liverpool led international clinical trial has found an anti-impotence drug to be ineffective at improving outcomes for pregnancies complicated by fetal growth restriction.
A new assessment, published in the December issue of the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology, reviewed the benefits and challenges of the Agency for Healthcare Research and Quality's Safety Program for Long-Term Care, a national preventive program that was implemented from 2013 to 2016 and aimed at reducing CAUTI across US nursing homes.
For prostate cancer patients who have rising levels of PSA (a cancer indicator) even after radical prostatectomy, early treatment makes a difference. In a study featured in the December issue of The Journal of Nuclear Medicine, Australian researchers demonstrate that PET scans can identify which of these prostate cancer patients would benefit from salvage radiation treatment (SRT).
The lack of truly effective and safe therapies for these challenges stems from insufficient knowledge of the biological mechanisms for urinary control, the impact of aging and disease on urinary control, and the relationships of symptoms to urinary health and overall well-being, so say researchers reporting on a prestigious conference hosted by the American Geriatrics Society and funded by a grant from the National Institute of Aging to George A. Kuchel, M.D., FRCP, AGSF, of UConn Health.
In a new study, DNA sequencing was used to uncover the genetic cause of kidney disease, influencing diagnosis and treatment.
A new study that included researchers from Norway, the University of Washington, the University of California San Diego and The University of Texas Health Science Center at San Antonio (now called UT Health San Antonio™) found that dozens of small molecules called metabolites are altered in this disease.
The Prostate Health Index (phi) is a cost-effective tool used by urologists to detect prostate cancer. It reduces the risk of over diagnosis, and cuts down on the need to send men for unnecessary and often uncomfortable biopsies. So says Jay White of Carolina Urology Partners in the US, lead author of a study in the journal Prostate Cancer and Prostatic Diseases, published by Springer Nature.
Scientists have discovered the 'genetic signatures' of the most common form of bladder cancer -- and it could open up the possibility of better-targeted treatment, according to research published today.